…
Renishaw plc, an engineering and scientific technology company, designs, manufactures, distributes, sells, and services technological products and services, and analytical instruments and medical devices worldwide. It operates through two segments: Manufacturing technologies; and Analytical instruments and medical devices. The company offers precision measurement and process control products, such as co-ordinate measuring machine probes, software, retrofits, equator gauging systems, fixtures, machine calibration and optimization, machine tool probes, precision styli for metrology, and smart manufacturing data platform; and position and motion control products comprising interferometric laser, magnetic, and optical encoders. It also provides healthcare products, such as neuromate stereotactic robots, neuroinfuse drug delivery systems, neuroinspire surgical planning software, dixi medical's, and Raman spectrometers; industrial robots; and additive 3D printing manufacturing systems. It serves the aerospace, automotive, consumer electronics, medical and healthcare, heavy, machine builder, energy, and precision manufacturing industries, as well as scientific, research, and analysis industries. The company was incorporated in 1973 and is based in Wotton-under-Edge, the United Kingdom.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
| Income before tax | 118.00M | 122.59M | 145.06M | 145.59M | 139.44M |
| Minority interest | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Net income | 83.76M | 96.89M | 116.10M | 120.35M | 111.46M |
| Selling general administrative | 77.10M | 75.08M | 74.89M | 69.74M | 69.26M |
| Selling and marketing expenses | 144.03M | 139.90M | 137.74M | 122.45M | 110.09M |
| Gross profit | 330.83M | 421.74M | 350.67M | 357.55M | 295.71M |
| Reconciled depreciation | 35.75M | 32.83M | 30.27M | 36.03M | 39.00M |
| Ebit | 110.21M | 123.24M | 145.47M | 158.36M | 118.79M |
| Ebitda | 133.90M | 156.07M | 175.73M | 194.39M | 157.80M |
| Depreciation and amortization | 23.69M | 32.83M | 30.27M | 36.03M | 39.00M |
| Operating income | 107.89M | 108.67M | 134.49M | 143.25M | 138.34M |
| Other operating expenses | 605.16M | 582.63M | 552.68M | 517.41M | 449.20M |
| Interest expense | 6.04M | 0.64M | 0.73M | 0.95M | 1.33M |
| Tax provision | 34.24M | 25.70M | 28.96M | 25.23M | 27.98M |
| Interest income | 13.16M | 12.02M | 7.94M | 0.83M | 0.62M |
| Net interest income | 7.12M | 11.37M | 7.21M | -0.12M | -0.71M |
| Income tax expense | 34.24M | 25.70M | 28.96M | 25.23M | 27.98M |
| Total revenue | 713.04M | 691.30M | 688.57M | 671.08M | 565.56M |
| Total operating expenses | 222.95M | 218.28M | 214.78M | 203.89M | 179.34M |
| Cost of revenue | 382.21M | 269.56M | 337.91M | 313.53M | 269.85M |
| Total other income expense net | 10.12M | 13.93M | 7.59M | -7.77M | 22.86M |
| Net income from continuing ops | 83.76M | 96.89M | 116.10M | 120.35M | 111.46M |
| Net income applicable to common shares | - | - | 116.10M | 120.35M | 111.46M |
| Breakdown | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
| Total assets | 1135.22M | 1051.38M | 1043.54M | 992.77M | 856.88M |
| Intangible assets | 2.53M | 36.11M | 35.23M | 32.77M | 33.29M |
| Other current assets | 60.02M | 26.45M | 174.87M | 174.87M | 169.19M |
| Total liab | 209.36M | 148.56M | 146.88M | 177.60M | 153.55M |
| Total stockholder equity | 926.44M | 903.40M | 897.24M | 815.75M | 703.91M |
| Deferred long term liab | - | - | 32.44M | 28.75M | 25.48M |
| Other current liab | 106.76M | 50.62M | 80.77M | 101.75M | 79.27M |
| Common stock | 14.56M | 14.56M | 14.56M | 14.56M | 14.56M |
| Capital stock | 14.56M | 14.56M | 14.56M | 14.56M | 14.56M |
| Retained earnings | 901.17M | 876.99M | 871.78M | 798.54M | 674.60M |
| Other liab | - | - | 38.94M | 33.27M | 34.45M |
| Good will | 10.85M | 11.23M | 11.23M | 11.45M | 10.51M |
| Other assets | - | - | 139.50M | 112.42M | 65.50M |
| Cash | 87.42M | 122.29M | 81.39M | 153.16M | 95.01M |
| Total current liabilities | 137.46M | 100.95M | 102.32M | 132.70M | 103.98M |
| Current deferred revenue | - | 10.88M | -7.70M | -4.63M | -4.90M |
| Net debt | -71.78M | -103.75M | -68.06M | -136.90M | -75.00M |
| Short term debt | 4.76M | 4.71M | 7.70M | 4.63M | 4.90M |
| Short long term debt | 0.76M | 0.75M | 4.69M | 0.92M | 0.99M |
| Short long term debt total | 15.64M | 18.54M | 13.33M | 16.26M | 20.01M |
| Other stockholder equity | -2.10M | -2.92M | -886.34M | -813.10M | -689.16M |
| Property plant equipment | - | - | 294.49M | 253.80M | 258.67M |
| Total current assets | 628.30M | 586.62M | 573.11M | 590.51M | 497.76M |
| Net tangible assets | - | - | 883.21M | 800.28M | 685.60M |
| Short term investments | 186.23M | 95.54M | 125.00M | 100.00M | 120.00M |
| Net receivables | 135.17M | 180.41M | 123.43M | 127.55M | 148.97M |
| Long term debt | 2.12M | 2.77M | 0.00M | 5.16M | 6.46M |
| Inventory | 159.47M | 161.93M | 185.76M | 162.48M | 113.56M |
| Accounts payable | 25.94M | 21.33M | 21.55M | 30.95M | 24.71M |
| Accumulated other comprehensive income | 12.81M | 14.77M | - | - | - |
| Treasury stock | - | - | - | - | -0.40M |
| Non currrent assets other | 115.34M | 130.00M | 87.12M | 60.77M | 18.73M |
| Non current assets total | 506.93M | 464.76M | 470.43M | 402.25M | 359.12M |
| Capital lease obligations | 12.76M | 15.02M | 8.63M | 10.18M | 12.56M |
| Breakdown | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
| Investments | -128.64M | -31.50M | -94.68M | -6.65M | -110.75M |
| Change to liabilities | - | - | -15.01M | 12.29M | 27.22M |
| Total cashflows from investing activities | -128.64M | -31.50M | -94.68M | -6.65M | -133.81M |
| Net borrowings | -0.79M | -0.80M | -5.12M | -5.05M | -7.66M |
| Total cash from financing activities | -55.81M | -52.70M | -61.40M | -55.89M | -18.23M |
| Change to operating activities | - | - | -1.49M | -2.02M | 0.67M |
| Net income | 83.76M | 96.89M | 116.10M | 120.35M | 111.46M |
| Change in cash | -34.87M | 40.91M | -71.77M | 58.15M | -15.38M |
| Begin period cash flow | 122.29M | 81.39M | 153.16M | 95.01M | 110.39M |
| End period cash flow | 87.42M | 122.29M | 81.39M | 153.16M | 95.01M |
| Total cash from operating activities | 147.90M | 124.08M | 84.30M | 121.47M | 135.29M |
| Depreciation | 32.94M | 32.83M | 30.27M | 36.03M | 39.00M |
| Other cashflows from investing activities | -82.37M | 29.27M | 7.23M | 11.94M | 0.62M |
| Dividends paid | 55.42M | 55.41M | 53.41M | 49.49M | 10.19M |
| Change to inventory | 2.46M | 23.83M | -23.27M | -48.92M | -8.07M |
| Change to account receivables | -11.03M | -23.72M | -12.38M | -11.30M | -25.70M |
| Sale purchase of stock | -0.15M | 0.00M | -2.21M | -0.75M | - |
| Other cashflows from financing activities | 4.84M | 3.51M | -7.99M | -6.40M | -4.57M |
| Change to netincome | - | - | -9.92M | 15.04M | -9.29M |
| Capital expenditures | 46.27M | 74.77M | 84.85M | 39.66M | 23.72M |
| Change in working capital | -7.43M | 3.91M | -52.15M | -49.95M | -5.88M |
| Stock based compensation | 0.79M | 0.88M | 0.68M | 0.18M | 0.17M |
| Other non cash items | 37.84M | -10.43M | -7.21M | -1.29M | 0.66M |
| Free cash flow | 101.62M | 49.30M | -0.55M | 81.81M | 111.57M |
Sector: Technology Industry: Scientific & Technical Instruments
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| RSW Renishaw PLC |
145.00 2.70% |
5520.00 | 36.80 | 20.41 | 3.70 | 2.87 | 3.25 | 15.89 |
| OXIG Oxford Instruments PLC |
74.00 2.87% |
2648.00 | 95.78 | 21.41 | 2.97 | 3.94 | 2.84 | 27.01 |
| JDG Judges Scientific Plc |
-25.00 0.74% |
3375.00 | 53.21 | 21.01 | 2.01 | 3.38 | 2.26 | 9.70 |
| SRT SRT Marine Systems plc |
0.50 0.74% |
68.50 | 87.00 | 8.15 | 2.13 | 7.62 | 2.24 | 32.10 |
| QTX Quartix Holdings Plc |
- -% |
230.00 | 17.31 | 13.85 | 3.05 | 3.28 | 2.89 | 8.64 |
Renishaw plc, an engineering and scientific technology company, designs, manufactures, distributes, sells, and services technological products and services, and analytical instruments and medical devices worldwide. It operates through two segments: Manufacturing technologies; and Analytical instruments and medical devices. The company offers precision measurement and process control products, such as co-ordinate measuring machine probes, software, retrofits, equator gauging systems, fixtures, machine calibration and optimization, machine tool probes, precision styli for metrology, and smart manufacturing data platform; and position and motion control products comprising interferometric laser, magnetic, and optical encoders. It also provides healthcare products, such as neuromate stereotactic robots, neuroinfuse drug delivery systems, neuroinspire surgical planning software, dixi medical's, and Raman spectrometers; industrial robots; and additive 3D printing manufacturing systems. It serves the aerospace, automotive, consumer electronics, medical and healthcare, heavy, machine builder, energy, and precision manufacturing industries, as well as scientific, research, and analysis industries. The company was incorporated in 1973 and is based in Wotton-under-Edge, the United Kingdom.
New Mills, Wotton-under-Edge, United Kingdom, GL12 8JR
44 1453 524 524
4975
| Name | Title | Year Born |
|---|---|---|
| Sir David R. McMurtry CBE, CEng, FIMechE, FREng, FRS, RDI | Co-Founder & Exec. Chairman | 1940 |
| Mr. William Lee M.A., M.B.A. | Chief Exec. & Director | NA |
| Mr. David John Deer | Co-Founder & Non-Exec. Deputy Chairman | 1938 |
| Mr. Allen C. G. Roberts F.C.A., FCA | Group Fin. Director & Director | 1949 |
| Mr. Dave Wallace | Director of Group Operations | 1971 |
| Ms. Jacqueline Conway | Gen. Counsel & Company Sec. | NA |
| Mr. Chris Pockett | Head of Communications | NA |
| Mr. Leo Somerville | Pres of Americas | 1958 |
| Mr. Rhydian Pountney | Managing Director of UK & ROW | 1961 |
| Mr. Rainer Lotz | Pres of EMEA | 1965 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.